JMJuliana Mariano R. B. Mello

Juliana Mariano R. B. Mello

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juliana Mariano R. B. Mello has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artificial intelligence in breast imaging

    by Juliana Mariano R. B. Mello

    Much has been discussed regarding artificial intelligence (AI) and its practical implications for the daily workflow of radiologists(1 1 Yoon JH, Strand F, Baltzer PAT, et al. Standalone AI for breast cancer detection at screening digital mammography and digital breast tomosynthesis: a systematic review and meta-analysis. Radiology. 2023;307:e222639. 2 Rodriguez-Ruiz A, Lång K, Gubern-Merida A, et al. Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists. J Natl Cancer Inst. 2019;111:916-22. -3 3 Brunetti N, Calabrese M, Martinoli C, et al. Artificial intelligence in breast ultrasound: from diagnosis to prognosis-a rapid review. Diagnostics (Basel). 2022;13:58. ). While there are ongoing debates regarding legal and data protections, AI is gaining ground, especially in the scientific community, where everything usually starts and where ideas about future directions in the medical field are initially influenced. There have been a number of studies comparing the diagnostic performance of AI with that of radiologists in various countries. In a recent meta-analysis, AI demonstrated diagnostic accuracy equal to or greater than that of radiologists(1 1 Yoon JH, Strand F, Baltzer PAT, et al. Standalone AI for breast cancer detection at screening digital mammography and digital breast tomosynthesis: a systematic review and meta-analysis. Radiology. 2023;307:e222639. ). However, the authors noted that, in comparison with radiologists, AI methods had higher sensitivity but lower specificity, suggesting a potential practical use of AI in breast cancer screening, assuming that a subsequent detailed analysis will be performed by a radiologist. It is noteworthy that the authors of that meta-analysis cited potential conflicts of interest, detailing their relationships with AI software manufacturers(1 1 Yoon JH, Strand F, Baltzer PAT, et al. Standalone AI for breast cancer detection at screening digital mammography and digital breast tomosynthesis: a systematic review and meta-analysis. Radiology. 2023;307:e222639. ).


  • Open Access

    Inteligência artificial na imaginologia mamária

    by Juliana Mariano R. B. Mello

    Muito tem sido discutido a respeito da inteligência artificial (IA) e suas consequências práticas no fluxo de trabalho diário do médico radiologista(1 1 Yoon JH, Strand F, Baltzer PAT, et al. Standalone AI for breast cancer detection at screening digital mammography and digital breast tomosynthesis: a systematic review and meta-analysis. Radiology. 2023;307:e222639. 2 Rodriguez-Ruiz A, Lång K, Gubern-Merida A, et al. Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists. J Natl Cancer Inst. 2019;111:916-22. -3 3 Brunetti N, Calabrese M, Martinoli C, et al. Artificial intelligence in breast ultrasound: from diagnosis to prognosis-a rapid review. Diagnostics (Basel). 2022;13:58. ). Ainda precisando avançar em vários aspectos médico-legais e de proteção de dados, a IA vem ganhando espaço principalmente no meio científico, onde tudo ocorre primeiramente e onde as ideias de projeções futuras no cenário médico são primeiramente impactadas. Vários artigos já foram publicados no mundo, comparando a performance diagnóstica da IA com a do médico radiologista. Em uma recente meta-análise, a IA demonstrou uma acurácia diagnóstica igual ou superior à dos médicos radiologistas(1 1 Yoon JH, Strand F, Baltzer PAT, et al. Standalone AI for breast cancer detection at screening digital mammography and digital breast tomosynthesis: a systematic review and meta-analysis. Radiology. 2023;307:e222639. ). Entretanto, notou-se uma maior sensibilidade dos métodos de IA, mas uma menor especificidade, quando comparada à performance dos radiologistas, sugerindo um possível uso prático da IA na radiologia mamária de rastreamento em si e posterior análise mais detalhada pelo médico radiologista. Há que se citar também os potenciais conflitos de interesse de vários dos autores e suas relações com possíveis fabricantes de softwares de IA, como declarado no próprio artigo(1 1 Yoon JH, Strand F, Baltzer PAT, et al. Standalone AI for breast cancer detection at screening digital mammography and digital breast tomosynthesis: a systematic review and meta-analysis. Radiology. 2023;307:e222639. ).


  • Achados de ressonância magnética de metástase de rabdomiossarcoma para mama: Relato de caso e revisão da literatura

    by Juliana M.R.B. Mello, João Edson Prediger, Bruno Rabolini, Eduardo N. Tavares, Fernando Bittelbrunn, Guilherme Zwetsch, Andrea P.S Damin

  • Open Access

    Mammographic and Ultrasonographic Imaging Analysis for Neoadjuvant Chemotherapy Evaluation: Volume Reduction Indexes That Correlate With Pathological Complete Response

    by Juliana M. Mello, Flavia Sarvacinski, Flavia C. Schaefer, Daniel S. Ercolani, Nathalia R. Lobato, Yasmine C. Martins, Guilherme Zwetsch, Fernando P. Bittelbrunn, Charles F. Ferreira, Andrea P. Damin

    Introduction: We aimed to evaluate volume reduction in digital mammography (DM) and ultrasound (US) for neoadjuvant chemotherapy (NAC) evaluation, with breast cancer-specific survival and pathological complete response (pCR) associations. Methods: This is a retrospective observational cohort study analyzing recorded images in 122 selected subjects out of which 569 patients presented with advanced breast cancers. Spearman’s correlation and generalized estimating equations (GEE) compared volume reduction on DM and US between pCR and non-pCR after NAC with post-surgical anatomopathology. Cox regression and Kaplan-Meier curves analyzed associations between cancer-specific survival, pCR, and volume reductions. Results: A total of 34.4% (N=42) obtained pCR and 65.6% (N=80) did not. Minimum percentage indexes needed to correlate with pCR over time were, at least, 28.9% for DM (p=0.006) and 10.36% for US (p=0.046), with high specificity (US=98%, DM=93%) but low sensitivity (US=7%, DM=18%). Positive predictive values were 82% (DM) and 86% (US) and negative predictive values were 37% (DM) and 36% (US). Cox regression and Kaplan-Meier curves demonstrated associations of breast cancer-specific survival with pCR (Cox regression coefficient {B}=0.209, CI 95%=0.048-0.914, p=0.038). Conclusions: At least 28.9% of volume reduction on DM and 10.36% of volume reduction on US are correlated with pCR. Furthermore, pCR was associated with breast cancer-specific survival after NAC in volumetric morphological imaging analysis.


  • Open Access

    Breast cancer mammographic diagnosis performance in a public health institution: a retrospective cohort study

    by Juliana M.R.B. Mello, Fernando P. Bittelbrunn, Marcio A. B. C. Rockenbach, Guilherme G. May, Leonardo M. Vedolin, Marilia S. Kruger, Matheus D. Soldatelli, Guilherme Zwetsch, Gabriel T. F. de Miranda, Saone I. P. Teixeira, et al.

    To evaluate the quality assurance of mammography results at a reference institution for the diagnosis and treatment of breast cancer in southern Brazil, based on the BIRADS (Breast Imaging Reporting and Data System) 5th edition recommendations for auditing purposes.